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Many epithelial pathologies induce loss of
apicobasal polarity. Epithelial intercellular
adhesion molecule 1 (ICAM-1) mediates
lymphocyte adhesion to hepatic epithelial
cells. Reglero-Real et al. now show that
polarized hepatocytes and bile duct
epithelial cells confine ICAM-1 to their
apical membrane domains, which are
less accessible to circulating immune
cells. Upon depolarization, apical ICAM-
1 is exposed and increases lymphocyte
binding. Epithelial apicobasal polarity
thus helps the immune system to discrim-
inate between normal and depolarized,
dysfunctional hepatic cells exposing their
adhesion machinery.
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Loss of apicobasal polarity is a hallmark of epithelial
pathologies. Leukocyte infiltration and crosstalk with
dysfunctional epithelial barriers are crucial for the in-
flammatory response. Here, we show that apicobasal
architecture regulates the adhesion between hepatic
epithelial cells and lymphocytes. Polarized hepato-
cytes and epithelium from bile ducts segregate the
intercellular adhesion molecule 1 (ICAM-1) adhesion
receptor onto their apical, microvilli-richmembranes,
which are less accessible by circulating immune
cells. Upon cell depolarization, hepatic ICAM-1 be-
comes exposed and increases lymphocyte binding.
Polarized hepatic cells prevent ICAM-1 exposure
to lymphocytes by redirecting basolateral ICAM-1
to apical domains. Loss of ICAM-1 polarity occurs
in human inflammatory liver diseases and can be
induced by the inflammatory cytokine tumor necro-
sis factor alpha (TNF-a). We propose that adhesion
receptor polarization is a parenchymal immune
checkpoint that allows functional epithelium to
hamper leukocyte binding. This contributes to the
haptotactic guidance of leukocytes toward neigh-
boring damaged or chronically inflamed epithelial
cells that expose their adhesion machinery.INTRODUCTION
Hepatocytes are polarized epithelial cells that delimit an apical
lumen that forms channels for draining bile, the bile canaliculi
(BCs), and a basolateral membrane that is exposed to the space
of Disse and interacts with the sinusoids, extravasated leuko-
cytes, and other parenchymal cells (Lee, 2012; Wang and Boyer,Cell Re2004). BCs drain into bile ducts, which are formed by polarized
epithelial cells called cholangiocytes (Lee, 2012). A correct polar-
ized architecture is necessary for hepatic epithelial cell function,
and loss of hepatic apicobasal polarity is a hallmark of liver pa-
thology. Hepatocytes injured after trauma, hepatoma cells, and
hepatocytes infected with hepatitis B virus (HBV) or hepatitis C
virus (HCV) lose their polarity (Benedicto et al., 2011; Mee
et al., 2010; Shousha et al., 2004). Reduced hepatocyte polariza-
tion has been found in biopsies of liver carcinomas and livers at
different stages of cirrhosis or hepatitis infection (Shousha et al.,
2004).
Leukocyte infiltration into the liver is essential for immune
surveillance, controls cancer and infections, and facilitates tis-
sue regeneration. Aberrant leukocyte-hepatocyte interactions
trigger liver failure in autoimmune diseases and rejection after
transplantation, and exacerbate liver damage upon severe
trauma. Hepatocyte death, injury, oncogenic transformation,
and virus infection promote extravasation across the sinusoids
of immune cells, which search for antigen presentation,
damaged or transformed cells, cell debris, or microorganisms
(Hiraoka, 2010; Holz et al., 2010; Kang et al., 2011). Efficient
leukocyte migration in the parenchyma involves various molecu-
lar cues, including secreted chemokines and cytokines, and
haptotactic factors such as extracellular matrix components
and adhesion receptors exposed on sinusoidal and parenchymal
cell surfaces (Edwards et al., 2005; McGettrick et al., 2012). The
interaction between leukocyte b2 integrins and intercellular
adhesion molecule 1 (ICAM-1) is of central importance in the
epithelial inflammatory response (Chin and Parkos, 2007). The
molecular mechanisms that regulate leukocyte adhesion to he-
patic epithelial cells have not yet been investigated in detail;
however, a role for hepatic ICAM-1 as a counterreceptor of
leukocyte integrins for neutrophils, T cells, and T cell hybridomas
has been reported (Meijne et al., 1994; Morita et al., 1994; Na-
gendra et al., 1997).
Here we demonstrate that apicobasal polarity negatively
regulates lymphocyte adhesion to hepatic cells through theports 8, 1879–1893, September 25, 2014 ª2014 The Authors 1879
confinement of ICAM-1 in their apical membrane domains, which
are not accessible by immune cells. This confinement is ob-
served both in vitro and in vivo and is regulated by the proinflam-
matory cytokine tumor necrosis factor alpha (TNF-a). Our results
indicate that in dysfunctional hepatic parenchyma, leukocytes
appear to discriminate between operative hepatocytes that
segregate adhesion receptors onto BCs and depolarized and
chronically inflamed adjacent hepatocytes that expose their
adhesion machinery.
RESULTS
Loss of Apicobasal Polarity Increases Lymphocyte
Adhesion to HepG2 Cells
To investigate the effect of the loss of hepatocellular polarity on T
lymphocyte adhesion, we first took advantage of the hepatoma
cell line HepG2, which retains the main polarity features of pri-
mary hepatocytes and is thus a prototypical model for investi-
gating apicobasal polarity (Madrid et al., 2010; van IJzendoorn
et al., 1997). Depending on the cell passage, 40%–60% of
HepG2 cells showed a polarized morphology, forming colonies
containing spherical or tubular apical lumens between two or
more cells (Figure 1A, left). These lumens are sealed by cell-
cell junctions and are reminiscent of bona fide BCs (Madrid
et al., 2010). It has been reported that classical PKC activation
with phorbol esters, such as phorbol-12 myristate-13 acetate
(PMA), reduces HepG2 polarization, whereas analogs of cyclic
AMP (cAMP), such as dibutyryl-cAMP (dcAMP), promote the
formation of BCs (Fu et al., 2011; Zegers and Hoekstra, 1997).
We first analyzed the effect of PMA and dcAMP on HepG2 cell
polarity and interaction with T lymphocytes. We addressed cell
polarity by counting the number of BCs, as identified by double
staining of F-actin and the glycosylphosphatidylinositol (GPI)-
anchored protein CD59, which partially accumulates in the
BCs (Figure 1A) or by double staining with the canalicular
markers multidrug resistance-associated protein 2 (Mrp-2) and
phosphorylated ezrin-radixin-moesin (ERM) proteins (Kikuchi
et al., 2002; Figure S1). PMA reduced the number of BCs by
70% (Figure 1A) and the percentage of polarized cells to 10%–
20% of total HepG2 cells. In contrast, dcAMP increased them
by 23% respect to untreated cells. Interestingly, after extensive
washes, PMA-treated HepG2 cells increased T cell adhesion
by 71%, whereas dcAMP-treated HepG2 cells decreased it by
22% (Figure 1B). Signaling pathways that regulate cell polarity
are involved in the inflammatory response (Mashukova et al.,
2011) and can induce the expression of adhesion receptors
that interact with immune cells (Delpino et al., 2010). To test
whether the inverse correlation between apicobasal polarity
and T cell adhesion could be attributed to the de novo synthesis
of surface adhesion receptors, we performed depolarization as-
says in the presence of the inhibitor of protein biosynthesis
cycloheximide (CHX). We observed no significant effect of
CHX on polarity (not shown) or lymphocyte adhesion (Figure 1B)
in either control or PMA-pretreated HepG2 cells, which indicates
that this increase in T cell adhesion is independent of de novo re-
ceptor synthesis.
To rule out the possibility that PMA or dcAMP affect hepatic
cell-leukocyte adhesion independently of the modulation of api-1880 Cell Reports 8, 1879–1893, September 25, 2014 ª2014 The Aucobasal polarity, we followed an alternative strategy and tar-
geted the Cdc42-mediated signaling axis in HepG2 cells, which
plays a central role in the generation of cell polarity. The Rho
GTPase Cdc42 serves as a master regulator of cell polarity by
controlling vesicular trafficking, cell-cell junctions, and signaling
pathways that mediate cell polarization (Madrid et al., 2010;Mar-
tin-Belmonte et al., 2007). Cdc42 knockdown with two small
interfering RNA (siRNA) oligonucleotides reduced the number
of BCs in HepG2 cells to 52% and 53% of those found in cells
transfected with siRNA control (Figures 1C and 1D). This reduc-
tion of polarity correlated with an increased adhesion of human
primary T lymphocytes to hepatic cells by 35% and 27%,
respectively (Figure 1E). Cdc42 regulates the partitioning-defec-
tive (PAR) polarity complex, which comprises the proteins PAR3,
PAR6, and atypical protein kinase C (aPKC), and promotes the
establishment of the apical-basal membrane border (Martin-
Belmonte and Mostov, 2008). aPKC can be inhibited with a
pseudosubstrate peptide (PS-aPKC) that impairs apical lumen
morphogenesis (Martin-Belmonte et al., 2007). Similarly to
Cdc42 knockdown, PS-aPKC reduced the number of BCs by
almost 50% (Figure 1F) and increased lymphocyte adhesion by
62% (Figure 1G). Finally, in the absence of depolarizing treat-
ment, we found that T lymphocytes preferentially adhered to
the subpopulation of unpolarized hepatic cells (Figure 1H). In
summary, by modulating the polarity of HepG2 cells using four
different approaches, we identified an inverse correlation be-
tween their apicobasal architecture and their ability to interact
with T lymphocytes.
ICAM-1 Is Confined in the BCs of Polarized Hepatocytes
and Exposed to Lymphocytes upon Loss of Polarity
In the liver parenchyma, infiltrated leukocytes preferentially
establish contacts with the basolateral membranes of polarized
hepatic cells, which are exposed to the sinusoids (Warren et al.,
2006). The b2 integrin counterreceptor ICAM-1 mediates leuko-
cyte adhesion to endothelial and epithelial cells (Meijne et al.,
1994; Reglero-Real et al., 2012). Confocal analysis of polarized
HepG2 cells and human primary hepatocytes revealed low levels
of ICAM-1 staining at basolateral membrane domains. The re-
ceptor was mostly confined to the BCs, where it colocalized
with F-actin-rich microvilli (Figures 2A and 2B) and was sur-
rounded by cell-to-cell junctional markers such as desmosomal
desmoglein-2 (Dsg-2) (Figure S2A). The distribution of ICAM-1
was comparable to that of other canalicular markers, such as
radixin, Mrp-2, and active phosphorylated ERM (p-ERM) pro-
teins (ezrin [T567], radixin [T568], and moesin [T558] (Figure 2B;
Kikuchi et al., 2002). Upon induction of HepG2 cell depolariza-
tion, canalicular ICAM-1 was dispersed in discrete domains
distributed over the entire cell area (Figure 2C). These structures
were positive for F-actin and resembled the staining pattern of
ICAM-1-rich microvilli found in nonpolarized epithelial and endo-
thelial cells (Figure 2C, inset; Milla´n et al., 2006). Phosphorylation
at a specific threonine residue close to the C terminus is required
to promote the open conformation of active ERMs (Ivetic and
Ridley, 2004), which regulate microvilli by connecting F-actin to
plasma membrane proteins. Untreated, polarized HepG2 cells
accumulated active p-ERM proteins in the apical membranes
(Figure 2D), as occurs in primary hepatocytes (Figure 2B; Kikuchithors
Figure 1. Epithelial Apicobasal Polarity
Regulates T Lymphocyte Adhesion
(A) Confocal images of untreated HepG2 cells
(Control) or cells treated for 2 hr with 100 nM PMA
or with 100 mm dcAMP, fixed, and stained for
CD59 and F-actin to identify apical membrane
domains that form BCs (asterisks). The bottom-
right graph shows the quantification of BCs. *p =
0.008; **p = 0.002; n = 3.
(B) HepG2 cells were treated as in (A). When
indicated, protein biosynthesis was inhibited by
coincubation with 1 mg/ml CHX. Cells were then
extensively washed and incubated with calcein-
labeled T lymphocytes for 15 min, rinsed, fixed,
and stained for F-actin to visualize HepG2 and
T cells. Discontinuous lines in confocal images
mark calcein-positive T cells. Lymphocyte adhe-
sion was quantified by measuring calcein fluo-
rescence in a plate reader (bottom-right graph).
*p = 0.008, n = 6; **p = 0.001, n = 8; ***p = 0.0007,
n = 5.
(C) HepG2 cells were transfected with siRNA
control (siControl) or two different siRNAs specific
for Cdc42 (siCdc42) for 72 hr. Western blot of
Cdc42 and ERK in siRNA-transfected cells.
Bottom graph: quantification of Cdc42 levels ex-
pressed as arbitrary units (A.U.). ERK expression
was used as a loading control. **p < 2.8 3 107;
n = 3.
(D) Cells transfected with the indicated siRNAs
were stained for F-actin and CD59 to identify (as-
terisks) and quantify (right graph) BCs. *p = 0.001;
**p = 0.0003; n = 3.
(E) siRNA-transfected HepG2 cells were incu-
bated with calcein-labeled T lymphocytes for
15 min, rinsed, fixed, and stained for F-actin.
Lymphocyte adhesion was quantified as in (B)
(bottom-right graph). *p = 0.031, n = 3; **p = 0.007,
n = 5.
(F and G) Quantification of BCs (*p = 0.003) (F) and
calcein-labeled T lymphocyte adhesion (*p =
0.043) (G) in untreated HepG2 cells (control) or
HepG2 cells treated for 18 hr with 40 mg/ml of PS-
aPKC.
(H) Untreated HepG2 cells were incubated with
calcein-labeled T cells. The percentage of T cell
adhesion to polarized versus unpolarized HepG2
cells is shown. ***p = 0.0005, n = 3. Bars show the
mean + SEM. Scale bars represent 10 mm.
See also Figure S1.et al., 2002). Upon collapse of the BCs, active ERMs were local-
ized in sparse, discrete domains on the plasma membrane—a
redistribution pattern that was very similar to that of microvilli
and ICAM-1 (Figures 2C and 2D). Immunostaining of ICAM-1
prior to permeabilization of depolarized HepG2 cells stably ex-
pressing ICAM-1-GFP showed that ICAM-1 domains were
exposed on the cell surface (Figure 2E). Scanning electron mi-
croscopy of HepG2 cells revealed the appearance of long sur-
face filaments resembling canalicular microvilli upon induction
of depolarization (Figure 2F). In order to analyze quantitatively
whether plasma membrane ICAM-1 is more exposed to theCell Reextracellular milieu upon depolarization, we labeled surface pro-
teins of untreated or depolarized HepG2 cells in the cold with
membrane-impermeable sulfo-NHS-biotin, which could not
reach the BCs. Biotinylated (and thus exposed) ICAM-1 was
detected by pull-down assays with neutravidin-conjugated
agarose (Figure 2G). Although not all of the untreated HepG2
cells had a polarized phenotype before the induction of depolar-
ization, the exposed-to-total protein ratio clearly showed that
ICAM-1 and p-ERM proteins, which were associated with bio-
tinylated plasma membrane receptors, were more accessible
from the extracellular milieu in response to the depolarizingports 8, 1879–1893, September 25, 2014 ª2014 The Authors 1881
Figure 2. ICAM-1 Is Confined in BCs of Human Hepatocytes and Exposed upon Loss of Apicobasal Polarity
(A) HepG2 cells were grown for 72 hr, fixed, and stained for ICAM-1 and F-actin. The bottom right shows the fluorescence intensity profile along the white arrow
crossing a BC in the image.
(legend continued on next page)
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challenge. Cdc42 knockdown and incubation with PS-aPKC
also increased ICAM-1 dispersion (Figure S2B) and biotinylation
(Figure S2C). Altogether, these findings indicate that loss of po-
larity exposes actin- and ERM-rich canalicular microvilli contain-
ing ICAM-1 on cell surfaces.
Indeed, time-lapse analysis of T cells migrating on depolarized
HepG2 stably expressing ICAM-1-GFP showed local receptor
redistribution into microvilli-like protrusions surrounding the
adhered lymphocyte (Figure 3A, arrows; Movie S1). Extensive
confocal analysis followed by 3D image reconstruction also re-
vealed endogenous ICAM-1- and F-actin-rich membrane pro-
jections around lymphocytes adhered to unpolarized hepatic
cells (Figures 3B–3D). This membrane reorganization resembles
the endothelial docking structures that mediate leukocyte trans-
endothelial migration (TEM) (Barreiro et al., 2002; van Buul et al.,
2007). Finally, we tested whether ICAM-1 mediates lymphocyte
adhesion in depolarized HepG2 cells. HepG2 cells were trans-
fected with control siRNA or two different siRNA oligonucleo-
tides that efficiently knock down ICAM-1 (siICAM-1) (Figure 3E).
Cells were then depolarized with PMA+CHX and T cell adhesion
assays were performed. ICAM-1-depleted hepatic cells showed
a significant reduction in T cell adhesion, which was50%of the
increase in adhesion observed upon induction of depolarization
(Figures 3F and 1B). As a control, transfection of siICAM-1(2),
which targets the 50 UTR of ICAM-1 mRNA, did not reduce
ICAM-1-GFP expression (Figure 3E) and thus had no effect on
lymphocyte adhesion to HepG2 cells expressing exogenous
ICAM-1 (Figure 3F). These results imply that the effect of
ICAM-1 siRNA specifically results from a reduction in endo-
genous ICAM-1 expression. Consistent with these findings,
blocking antibodies against ICAM-1 or LFA-1 also reduced
lymphocyte adhesion to HepG2 cells (Figure 3G).
Polarized Hepatic Cells Prevent ICAM-1 Exposure to
Basolateral Membranes by Redirecting Basolateral
ICAM-1 to BCs
To investigate the mechanisms whereby polarized cells prevent
ICAM-1 localization at basolateral domains that face circulat-
ing immune cells, we first studied the dynamics of polarized
ICAM-1. ICAM-1 fused from its cytoplasmic C terminus to a pho-
toactivatable GFP (paGFP) protein was generated and stably ex-
pressed in HepG2 cells (Patterson and Lippincott-Schwartz,
2002). Like endogenous ICAM-1 (Figure 2A) and ICAM-1-GFP(B) Primary human hepatocytes were grown for 3 days in collagen sandwiches and
the fluorescence intensity profile along the white arrow crossing a BC. Primary hu
stained for ICAM-1, radixin, Mrp-2, or p-ERM proteins (right).
(C and D) HepG2 cells grown for 72 hr were depolarized with PMA+CHX for the
p-ERM proteins (D).
(E) HepG2 cells stably expressing ICAM-1GFP were depolarized as in (C) for 2
confocal microscopy.
(F) Scanning electron microscopy analysis of polarized and depolarized HepG2 c
are losing their polarity.
(G) HepG2 cells undergoing depolarization by PMA+CHX treatment at different
proteins (Exposed) were isolated by pull-down assay with neutravidin-agarose.
(H) The ratio of extracellularly exposed-to-total ICAM-1 is expressed as a percenta
3-fold upon loss of polarity and subsequently decayed at later times due to the co
4. Scale bars represent 10 mm.
See also Figure S2.
Cell Re(see Figure 5B), ICAM-1-paGFP was confined to the canalicular
membrane of polarized HepG2 cells (not shown). To identify
polarized cell colonies, actin-cherry was expressed in ICAM-1-
paGFP-HepG2 cells. ICAM-1-paGFP was first photoactivated
in the BCs and examined by time-lapse confocal microscopy
(Figures 4A and 4B; Movie S2). No significant decrease in fluo-
rescence was detected during the first 100 min poststimulation.
The increase in fluorescence in the adjacent basolateral regions
was also negligible, implying that ICAM-1-paGFP is remarkably
confined in BCs. Intracanalicular diffusion could not be
adequately analyzed due to the small size of these structures.
Polarized targeting to the canalicular surface of newly synthe-
sized proteins can take place by direct and indirect transport
routes. In the direct route, proteins from the Golgi are delivered
directly to the apical membrane. However, some apical proteins,
including a number of single-span transmembrane proteins, can
follow an indirect pathway and be segregated in the Golgi into
different carriers that transport them first to the basolateral mem-
brane and then to their final apical destination by transcytosis
(Bastaki et al., 2002). Similar to what was observed for endoge-
nous ICAM-1, only a minor fraction of ICAM-1-paGFP was local-
ized at the basolateral membrane domains. Importantly, this
fraction could be photoactivated, although it yielded much less
intense fluorescence (Figure 4C; Movie S3). Compared with
the slow apical-to-basolateral diffusion rate, ICAM-1-paGFP
completely diffused out from basolaterally photoactivated areas
within the first 10 min following photoactivation (Figures 4C and
4D; Movie S3). Long-term analysis of basolaterally photoacti-
vated ICAM-1-paGFP revealed that the receptor first diffused
within basolateral membranes and then accumulated progres-
sively in the BCs. Simultaneously, basolateral fluorescence
decreased, indicating the existence of a basolateral-to-apical
trafficking of ICAM-1 (Figures 4E and 4F; Movie S4). Therefore,
this population of basolaterally delivered ICAM-1 undergoes
subsequent redirection to the apical canaliculus in polarized he-
patic cells, where it can remain stable for at least 100 min.
Consistent with these results, although only a minor fraction of
ICAM-1 was localized in the basolateral membrane, basolateral
ICAM-1 (not shown) and ICAM-1-GFP (Figure 4G) could be
clearly labeled in live, unpermeabilized cells with a specific anti-
body. At 90 min after this immunolabeling, the antibody partially
accumulated in BCs, indicating a basolateral-to-apical transport
of labeled ICAM-1. Hence, these results indicate that thethen fixed and stained for ICAM-1 and F-actin (top left). The bottom left shows
man hepatocytes were grown for 5–6 days in collagen sandwiches, fixed, and
indicated times. Cell were fixed and stained for F-actin and ICAM-1 (C) or for
hr, incubated in the cold with anti-ICAM-1 antibody, fixed, and analyzed by
ells. The enlarged area shows microvilli-like protrusions appearing in cells that
times were incubated with sulfo-NHS-biotin and lysed. Surface-biotinylated
ge of the ratio in control cells. Surface ICAM-1 levels increased between 2- and
nstitutive internalization of surface proteins in CHX-treated cells. *p = 0.034, n =
ports 8, 1879–1893, September 25, 2014 ª2014 The Authors 1883
Figure 3. ICAM-1 Mediates T Cell Adhesion
to Depolarized Hepatic Epithelial Cells
(A) Depolarized HepG2 cells expressing ICAM-1-
GFP were incubated with CMTMR-labeled T lym-
phocytes and analyzed by time-lapse fluores-
cence microscopy and phase contrast. Arrows
indicate the accumulation of ICAM-1-GFP around
one adhered T lymphocyte.
(B) A z stack reconstruction of confocal images of
hepatic ICAM-1 surrounding adhered T lympho-
cytes labeled with CMTMR.
(C) Maximum intensity projection of the boxed
area in (B). The three orthogonal axes are indi-
cated.
(D) Maximum intensity projection of confocal
z-stacks of ICAM-1 and F-actin staining of a T cell
adhered to depolarized HepG2 cells. The three
orthogonal axes are indicated.
(E) Control HepG2 cells or HepG2 cells stably ex-
pressing ICAM-1-GFP were transfected with the
indicated siRNA oligonucleotides. After 72 hr, cells
were lysed and immunoblotted for the indicated
proteins. Exogenous ICAM-1 was not depleted by
siICAM-1(2). The bottom histogram quantifies
ICAM-1 levels in siICAM-1 transfected cells rela-
tive to siControl cells in arbitrary units (A.U.).
(F) Effect of the indicated siRNAs on T lymphocyte
adhesion to depolarized control HepG2 cells or
HepG2 cells stably expressing ICAM-1-paGFP, a
photoactivatable form of GFP that yields no fluo-
rescence in the plate reader. The discontinuous
line shows the percentage of T cell adhesion levels
in untreated and polarized HepG2 cells. *p =
0.041, n = 5; **p = 0.004, n = 3; ***p = 0.0004, n = 5;
****p = 5.3 3 105, n = 6.
(G) T lymphocyte adhesion assays to depolarized
HepG2 cells were performed in the presence of
the indicated blocking antibodies. *p = 0.044, n =
3; ***p = 3.618 3 107, n = 5. Bars show the
mean + SEM. Scale bars represent 10 mm.
See also Movie S1.substantive differences between basolateral-to-apical and
apical-to-basolateral trafficking of surface ICAM-1 prevent re-
ceptor localization at basolateral membranes, which in vivo are
exposed in the liver to the space of Disse, vasculature, and im-
mune cells.
ICAM-1 Associates with ERM Proteins at the Plasma
Membrane through Its Cytoplasmic Tail, which Is
Required for ICAM-1 Apical Localization
We next addressed which receptor domain is responsible for
ICAM-1 confinement in BCs. Basolateral localization of ICAM-1-
Dct-GFP, which lacks the receptor cytoplasmic tail, was
increased compared with the ICAM-1-GFP distribution, whereas
GFP fused to ICAM-1 lacking the extracellular domain (GFP-
ICAM-1-Dext) was sufficient to target GFP to BCs (Figures 5A–
5D). These results indicate that apical segregation of ICAM-1 is1884 Cell Reports 8, 1879–1893, September 25, 2014 ª2014 The Authorspartially dependent on its cytoplasmic
segment. To gain insight into the role of
the ICAM-1 cytoplasmic segment inICAM-1 polarity, we stably expressed ICAM-1-Dct-paGFP in he-
patic cells and analyzed its dynamics after photoactivation.
Absence of the cytoplasmic segment did not reduce the canalic-
ular confinement of ICAM-1-Dct-paGFP (Figures 5E and S3A;
Movie S5). In contrast, basolateral-to-apical trafficking was
clearly reduced compared with that of ICAM-1-paGFP (Figures
5F, S3B, and S3C; Movie S6), suggesting that the ICAM-1 cyto-
plasmic segment regulates the basolateral-to-apical traffic of
ICAM-1. Adhesion receptors from the immunoglobulin superfam-
ily, such as ICAM-1 and VCAM-1, can interact from their cyto-
plasmic tail with proteins that connect them to the subcortical
actin cytoskeleton, such as filamin, a-actinin, and the ERM pro-
teins (Barreiro et al., 2002; Carpe´n et al., 1992; Kanters et al.,
2008; Oh et al., 2007). Radixin and ezrin, which are the most
abundant ERM proteins in hepatocytes and hepatoma cells, are
essential for maintaining the BC structure and determine the
apical localization of canalicularmembraneproteins such asMrp-
2 (Gilbert et al., 2012; Kikuchi et al., 2002). We found that ICAM-1
colocalized with radixin and ezrin in polarized and depolarized
cells (Figure 5G). Furthermore, antibody-mediated crosslinking
of ICAM-1 induced radixin-YFP and ezrin-GFP coclustering at
the plasmamembrane in HepG2 cells (Figure 5H). ICAM-1 cross-
linking in primary human hepatocytes induced a significant co-
clustering of active ERM proteins (Figure S3D). This coclustering
depended on the receptor cytoplasmic segment, since ICAM-1
Dct-GFP clusters accumulated significantly fewer p-ERM pro-
teins at the plasma membrane of HepG2 cells compared with
ICAM-1-GFP clusters (Figure 5I). In accordance with this, pull-
down assays revealed that the ICAM-1 cytoplasmic tail as-
sociates with phosphorylated radixin and ezrin (Figure 5J). The
substitution of three lysine residues close to the transmembrane
segment of the receptor by leucine was sufficient to abrogate
the binding of hepatic ERM proteins to the receptor cytoplasmic
segment (Figures 5J and 5K) and induced a partial depolarization
of ICAM-1 (Figure 5L). This supports previous reports describing
the requirement of a short domain that contains basic amino
acids for the interaction between the ICAM-1 tail and actin con-
nectors in other cell types (Carpe´n et al., 1992; Oh et al., 2007).
ICAM-1-K>L-GFP was not as depolarized as ICAM-1-Dct-GFP,
which suggests that additional interactions of ICAM-1 tail with
other cytoplasmic proteins contribute to the receptor polarity.
Collectively, these results indicate that in hepatic cells, ICAM-1
is also associated with active ERM and F-actin in microvilli, a ma-
chinery that mediates leukocyte adhesion when exposed to leu-
kocytes (Reglero-Real et al., 2012) and also plays an important
role in the maintenance of apicobasal polarity (Kikuchi et al.,
2002; Wang et al., 2006).
Long-Term TNF-a Stimulation Activates ERM Proteins
at Basolateral Domains and Increases ICAM-1
Basolateral Exposure
ICAM-1 expression, ERMprotein activation, and leukocyte adhe-
sion are induced by the cytokine TNF-a (Aranda et al., 2013; Koss
et al., 2006), which is fundamental to long-term liver inflammatory
responses. We investigated the effect of long-term stimulation
by TNF-a on hepatocellular polarity and ICAM-1 expression
and polarization. HepG2 cells were stimulated at different times
and the distribution of ICAM-1 was analyzed. In conjunction
with a clear effect on ICAM-1 expression, immunofluorescence
and surface biotinylation assays revealed that TNF-a significantly
increased ICAM-1 and ICAM-1-GFP exposure to the extracel-
lular milieu (Figures 6A and 6B). Importantly, 24 hr of TNF-a stim-
ulation did not change the number of BCs in HepG2 cultures
(Figure 6C) or the distribution of the cell-to-cell junctional marker
ZO-1 (Figure S4A), which suggests that the increase of ICAM-1
basolateral localization is not a consequence of TNF-a-mediated
loss of apicobasal polarity. The analysis of TNF-a-induced
ICAM-1 depolarization in the presence of CHX revealed that de
novo synthesis of ICAM-1 is required for its basolateral localiza-
tion (Figure S4B), suggesting that newly synthesized ICAM-1 rea-
ches the basolateral domains first. Interestingly, TNF-a had no
effect on the apical confinement of ICAM-1 (Figure S4C; Movie
S7), but significantly reduced the basolateral-to-apical trafficking
of the receptor (Figures 6D and S4D).Cell ReTNF-a induced ERM phosphorylation in membrane protru-
sions at the basolateral membrane, which resembled surface
microvilli (Figure 6E). An overall increase in ERMphosphorylation
was also detected by western blot analysis, which showed that
this increment occurred before the increase in ICAM-1 (Fig-
ure 6F). ICAM-1 knockdown had no effect on ERM phosphoryla-
tion (not shown), ruling out a role for the receptor itself in ERM
activation. For correct function and localization, ERM proteins
must cycle between their active and inactive conformations (Vis-
wanatha et al., 2012). A constitutively active ERM mutant, ezrin
T567D GFP (ezrin-TD-GFP), was mislocalized to the basolateral
membrane. The expression of ezrin-TD-GFP was sufficient to
induce the basolateral accumulation of ICAM-1 in HepG2 cells
(Figure 6G) and to reduce basolateral-to-apical trafficking of
ICAM-1 in cells with morphologically intact BCs (Figures 6H
and S4E), similar to the reduction observed upon long-term
TNF- stimulation (Figures 6D and S4D). Expression of GFP alone
had no effect on ICAM-1 polarization (Figure S4F). Together,
these data indicate that basolateral ERM activation in response
to long-term TNF-a activation can contribute to basolateral
exposure of ICAM-1 without affecting the integrity of BCs in he-
patic cells. The basolateral increase of ICAM-1 occurs by the de-
livery of newly synthesized ICAM-1 to the basolateral membrane
and the subsequent slowdown of its basolateral-to-apical trans-
port. ERM protein loss-of-function experiments were shown to
affect overall hepatic cell polarization (Suda et al., 2011; Wang
et al., 2006), which prevented these strategies from being adop-
ted for further studies of ICAM-1 distribution.
PolarizedHepatocytes andBileDuct Epithelial Cells Can
Confine ICAM-1 to the Apical Membrane Domains
Finally, we studied ICAM-1 distribution in human tissue samples
from healthy donors and from patients with short-term or chronic
inflammatory liver dysfunction (Tables S1 and S2). First, we
analyzed samples from rejected human liver allografts that
were collected after a relatively short inflammatory response
by the host, which preserved their hepatocyte integrity in many
tissue areas. ICAM-1 was detected in the endothelial cells lining
the sinusoids, but also in hepatocytes that were concentrated in
BCs in areas that were apparently undamaged and showed no
leukocyte infiltration (Figure S5A, images R1–R3, arrows, right
insets). ICAM-1 expression was also significant in the sinusoids
from healthy control donors, but it was weak or absent in most of
the hepatocytes (Figure S5A, image Ct, arrows). Epithelial cells
from some bile ducts also expressed ICAM-1, always polarized
in the apical surface (Figure S5B). Hepatocytes expressing
polarized ICAM-1 were often found close to portal areas,
whereas small foci of parenchymal cells expressing depolarized
ICAM-1 were occasionally found dispersed in the parenchyma
(Figure S5C). Given that periportal hepatocytes are in proximity
to T cell infiltrates, ICAM-1 polarization may constitute a protec-
tive mechanism for healthy hepatocytes that potentially can be
exposed to immune cells. In contrast, in the parenchyma from
livers in advanced stages of HCV and HBV infection, we found
ICAM-1 confinement in BCs in some areas, but also a remark-
able loss of ICAM-1 polarization in others. Immunohistochemical
analysis of consecutive tissue sections, followed by accurate
pattern recognition based on duct, sinusoidal, and canalicularports 8, 1879–1893, September 25, 2014 ª2014 The Authors 1885
Figure 4. Basolateral ICAM-1 Is Redirected to and Confined in the BCs in Polarized HepG2 Cells
(A–F) ICAM-1 tagged with photoactivatable GFP (ICAM-1-paGFP) was photoactivated at the canalicular (apical) membrane (A and B) or the basolateral mem-
brane (C–F) of polarized HepG2 cells.
(A) Apically photoactivated ICAM-1-paGFP is confined in the BC. Cells were previously transfected with actin-Cherry to visualize BCs. Canalicular ICAM-1 was
photoactivated and its dynamics was analyzed by time-lapse confocal microscopy for more than 100 min. The asterisk marks the background fluorescence
emission prior to photoactivation (PA).
(B) Quantification of the relative fluorescence intensity in photoactivated canalicular areas (BC) and adjacent basolateral membrane regions after background
subtraction (n = 13 cells).
(C and D) Basolateral ICAM-1-paGFP was photoactivated and its dynamics was analyzed by time-lapse confocal microscopy for 10 min.
(D) Quantification of the relative fluorescence intensity in photoactivated and nonphotoactivated adjacent areas after background subtraction (n = 18 cells).
(E and F) Canalicular accumulation of basolaterally photoactivated ICAM-1. Basolateral ICAM-1-paGFP was photoactivated and its dynamics was analyzed by
time-lapse confocal microscopy for 100 min. Basolateral ICAM-1-paGFP rapidly diffused along the adjacent membrane regions as in (A). At later times,
(legend continued on next page)
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distribution, revealed a good correlation between the hepatic
accumulation of ICAM-1 and the CD10 canalicular marker in
some regions (Figures 7A and 7B). Similar to what was observed
in sections from allograft rejections, cholangiocytes from some
bile ducts strongly expressed and polarized ICAM-1 in luminal
membrane domains (Figure 7B). As previously reported (Shou-
sha et al., 2004), hepatocytes in many tissue regions lost
apicobasal polarity and as a consequence also displayed an un-
polarized ICAM-1 distribution (Figure 7C). However, a significant
number of hepatocytes that did not apparently polarize ICAM-1
still concentrated CD10 into canalicular-like structures (Fig-
ure 7D), suggesting the existence in vivo of mechanisms that
induce ICAM-1 basolateral exposure in polarized hepatocytes,
such as strong stimulation by inflammatory cytokines. Taken
together, these data reveal that hepatic parenchymal cells with
an intact apicobasal architecture can segregate the ICAM-1 re-
ceptor onto apical surfaces, which may not be accessible from
sinusoidal or perisinusoidal cells such as infiltrated leukocytes.
ICAM-1 loses its apical polarity in chronic liver diseases that
affect the hepatocyte architecture and cause persistent inflam-
matory stress.
DISCUSSION
Immunosurveillance plays a central role in clearing and receiving
information from dysfunctional epithelial cells in the parenchyma
(Chin and Parkos, 2007; Kang et al., 2011). However, the molec-
ular mechanisms that regulate the communication between im-
mune cells and the hepatic epithelium are still poorly understood.
ICAM-1 contributes to leukocyte adhesion to primary, nonpolar-
ized hepatocytes (Meijne et al., 1994; Morita et al., 1994) and to
hepatocyte-derived cell lines stimulated with a proinflammatory
cytokine cocktail (Nagendra et al., 1997). Here we show that un-
stimulated cultured HepG2 and primary hepatocytes, as well as
hepatocytes from undamaged hepatic parenchymal regions,
remarkably segregate ICAM-1 into apical plasma membranes.
Hepatic cells must lose polarity or be exposed to long-term in-
flammatory stimulation in order to make this receptor accessible
to immune cells. Hence, the polarized architecture of hepatic
cells emerges as a mechanism for modulating the intensity of
the inflammatory response in the liver. Recent reports indicated
that hepatocytes play a more important role in leukocyte adhe-
sion than expected, even before immune cells egress from the
hepatic microcirculatory system, since ICAM-1 on hepatocyte
microvilli directly contact leukocytes circulating by the sinusoids
through endothelial fenestrae (Warren et al., 2006). In this way,
ICAM-1 participates in antigen presentation to circulating, sinu-
soidal lymphocytes, which may be a determinant in the patho-
genesis of viral hepatitis or in liver-induced immune tolerance.fluorescence decreased from the basolateral regions and accumulated in the c
detected prior to PA.
(F) Quantification of fluorescence in basolateral and canalicular (BC) regions adja
(G) Basolateral ICAM-1 was labeled with anti-ICAM-1 antibody in polarized HepG
permeabilized, and stained with TRITC-conjugated secondary antibody. Basolate
incubation (arrowheads). Right graph: quantification of the percentage of BCs that
SEM. Scale bars represent 10 mm.
See also Figure S3 and Movies S2, S3, and S4.
Cell ReThus, hepatic ICAM-1 polarization may be relevant for both
innate and adaptive immune responses in the liver.
In hepatic cells exposing ICAM-1 upon depolarization, the re-
ceptor is reorganized into microvilli-derived structures that
embrace interacting lymphocytes. These structures are similar
to the docking complexes formed between ICAM-1 and ERM
proteins in endothelial cells, which are required for an efficient
leukocyte TEM (Barreiro et al., 2002; Reglero-Real et al., 2012).
However, in hepatocytes, active ERM proteins play roles other
than those described for leukocyte extravasation. The luminal
domain of hepatocytes delimits the BC, a channel in which
microvilli are abundant and the hepatocytes drain bile. Subcor-
tical filamentous actin and ERM proteins accumulate in BCs
and regulate cell polarity, canalicular microvilli, and canalicular
membrane localization of proteins such as the detoxifying trans-
porter Mrp-2 (Kikuchi et al., 2002; Wang et al., 2006). Our
data suggest that the ERM protein’s interaction with hepatic
ICAM-1 also plays a role in its polarized localization, which in
turn determines the lymphocyte-hepatic cell interaction. We pro-
pose that the dual role of the protein machinery formed by ERM
proteins and microvillar actin bundles (i.e., regulating either
lymphocyte adhesion or apicobasal polarity) underlies the in-
verse relation found between these two processes in hepatic
cells. When confined in canalicular microvilli, the machinery reg-
ulates hepatocellular polarity and drainage functions while it also
contributes to attenuate the inflammatory response by confining
adhesion receptors. Upon cell damage or persistent inflamma-
tion with cytokines such as TNF-a, the machinery is exposed
and plays haptotactic roles comparable to those observed in
endothelial cells.
Using different experimental strategies, we have also demon-
strated that the basolateral-to-apical traffic of ICAM-1 regulates
its polarity. The basolateral activation of ERM proteins by TNF-a
delays basolateral-to-apical trafficking of ICAM-1, probably by
retaining the receptor associated with basolateral actin struc-
tures (Oh et al., 2007). Further studies on the mechanisms that
regulate the activation of ERM proteins in different membrane
domains in hepatic cells may thus facilitate the development of
new therapeutic approaches to control the distribution of adhe-
sion receptors and liver function during inflammation.
Collectively, our data obtained in vitro indicate that in addition
to chemotactic gradients, hepatocellular polarity and the ex-
tension of the inflammatory response may provide haptotactic
cues that infiltrated leukocytes use to discriminate dysfunctional
hepatocytes from polarized, still-operative hepatocytes in dam-
aged parenchyma. Of note, the ICAM-1 distribution observed in
human tissue samples from livers with acute or long-term inflam-
matory dysfunction is consistent with our in vitro observations.
Liver allograft rejections and livers chronically infected withanalicular areas. The asterisk marks the background fluorescence emission
cent to photoactivated areas after background subtraction (n = 17 cells).
2 cells stably expressing ICAM-1-GFP. At the indicated times, cells were fixed,
rally labeled ICAM-1 receptor was partially found in BCs 90 min after antibody
were positive for basolateral ICAM-1. **p = 0.0002, n = 4. Bars show themean +
ports 8, 1879–1893, September 25, 2014 ª2014 The Authors 1887
(legend on next page)
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HBV and HCV accumulated ICAM-1 in BCs in areas that pre-
served hepatocyte integrity. However, the hepatitis virus-in-
fected livers clearly contained extensive parenchymal regions
that lost hepatic apicobasal polarity, as revealed by staining of
the canalicular marker CD10. They also had areas in which
ICAM-1 had an unpolarized distribution but CD10 was still
concentrated in canalicular-like structures, which is consistent
with the existence of a persistent inflammatory response that
promotes receptor basolateral accumulation in correctly polar-
ized hepatocytes. Several inflammatory and stress stimuli
contribute to ICAM-1 expression (Hubbard and Rothlein, 2000;
Morita et al., 1994; Zhu et al., 2005). Elucidating which stimulus
regulates ICAM-1 polarization in hepatic cells in each patholog-
ical scenario is a long-term task thatmay provide a new perspec-
tive on the control of liver inflammatory diseases.
Our data are in agreement with those of a previous study of
HBV-infected livers, in which parenchyma with mild HBV infec-
tion accumulated ICAM-1 in BCs, whereas parenchyma with
high levels of LFA-1-positive lymphocyte infiltration and an ex-
acerbated inflammatory response displayed a nonpolarized dis-
tribution of hepatocyte ICAM-1 (Doi et al., 1994). Although no
analysis of hepatocyte polarity was carried out in that particular
report, other researchers have shown that HCV and HBV liver in-
fections reduce hepatocyte polarity and contribute to the devel-
opment of a hepatocellular-transformed phenotype (Akkari et al.,
2012; Kew, 2011; Wilson et al., 2012). Considering all these data
together, we envisage that ICAM-1 basolateral exposure may
help immune cells to identify hepatocytes in advanced stages
of virus infection.
Mechanisms of apicobasal polarity are preserved in different
epithelia, where the accessibility of immune cells to the lumens
and internal cavities may be reduced relative to that in paren-
chymal spaces (Weisz and Rodriguez-Boulan, 2009). Therefore,Figure 5. ICAM-1 Apical Polarization and Association with Hepatic Ra
(A–D) The ICAM-1 cytoplasmic tail is required for full ICAM-1 apical polarization.
(A) Schematic of full and truncated ICAM-1 chimeras ectopically expressed in po
(B) HepG2 cells stably expressing ICAM-1-GFP and ICAM-1-Dct-GFP were gro
GFP-ICAM-1-Dext was toxic, so this chimera could only be transiently expresse
(C and D) Quantification of the basolateral-to-apical ratio (basolateral index) of th
GFP increased basolateral distribution, whereas the receptor transmembrane and
107, n = 3. (D) *p = 2.2 3 105, **p = 6.4 3 106, n = 3.
(E) Apically photoactivated ICAM-1-Dct-paGFP is confined in the BC. Canalicul
confocal microscopy for more than 100min. Quantification of the relative fluoresce
membrane regions after background subtraction (n = 14 cells) is shown.
(F) Reduced basolateral-to-apical transport of photoactivated ICAM-1-Dct-paG
adjacent to photoactivated areas after background subtraction (n = 15 cells) is s
(G) HepG2 cells expressing radixin (RDX)-YFP or ezrin-GFP were left untreated o
(H) Endogenous ICAM-1 was engaged with specific mouse antibodies in the col
ICAM-1) in cells expressing the indicated fluorescent proteins. The graph shows th
X-ICAM-1 and the indicated fluorescent proteins. The ratio of YFP/GFP-positive
0.002; n = 3.
(I) HepG2 cells stably expressing ICAM-1-GFP or ICAM-1-Dct-GFP were knocked
(X-ICAM-1), fixed, and stained for p-ERMs. The Manders coefficient shows the G
(J) Radixin and ezrin associate with the ICAM-1 cytoplasmic tail. Top, Coomassie
with recombinant GST alone and GST containing the ICAM-1 cytoplasmic segm
(K) HepG2 cells stably expressing ICAM-1-K>L-GFP were knocked down for end
stained for p-ERMs.
(L) Parallel quantification of the basolateral index for ICAM-1-GFP and ICAM-1-K
10 mm.
See also Figure S3 and Movies S5 and S6.
Cell Repolarization of epithelial receptors involved in adhesion and acti-
vation of immune cells may be a general mechanism to prevent
exacerbation of the immune response that is not restricted to he-
patic tissues. Indeed, an apical distribution of ICAM-1 has also
been reported in human intestinal epithelia, in which this recep-
tor mediates apical-to-basolateral leukocyte transmigration
(Parkos et al., 1996). Since loss of polarity is a general feature
of epithelial cell dysfunction, we propose that the differential
exposure of adhesion receptors that occurs as a consequence
is an immune checkpoint for maintaining epithelial tissues free
of damaged or transformed cells.
EXPERIMENTAL PROCEDURES
Cells
Human hepatoma HepG2 cells were grown in high-glucose Dulbecco’s modi-
fied Eagle’s medium supplemented with 5% fetal bovine serum (Sigma). For
stable expression of exogenous proteins, transfected cells were selected by
treatment with 0.5 mg/ml G-418 sulfate for at least 4 weeks after transfection.
Positive cell clones were maintained in drug-free medium. After several pas-
sages in this medium, >90% of cells retained expression of the exogenous
product. Primary human hepatocytes were grown in collagen sandwiches
with HCM medium (Lonza) for 5 days to induce polarization as previously
described (Tolosa et al., 2011). T lymphoblasts were prepared from isolated
human peripheral blood mononuclear cells (PBMCs). Nonadherent PBMCs
were stimulated with 0.5% phytohemagglutinin for 48 hr and maintained in
interleukin-2 as previously described (Milla´n et al., 2006). T lymphoblasts
were used in experiments after they were cultured for 7–12 days.
Modulation of HepG2 Polarity
In addition to Cdc42 siRNA transfection, HepG2 cell polarity was reduced by
treatment with 100 nM PMA for up to 4 hr (Zegers and Hoekstra, 1997) or
with 40 mg/ml PS-aPKC for 18 hr. Polarity was increased by treatment with
100 mM dcAMP for 2 hr as previously described (Zegers and Hoekstra,
1997). Morphological analyses and BC quantitation were performed by stain-
ing for F-actin and CD59 in fixed HepG2 cells or primary hepatocytes.dixin and Ezrin Require an Intact Receptor Cytoplasmic Tail
larized HepG2 cells.
wn for 72 hr and then fixed and stained for F-actin. Long-term expression of
d. Intracellular accumulation of the protein was also detected.
e indicated proteins normalized to the F-actin basolateral index. ICAM-1-Dct-
tail domains were sufficient to localize GFP in the BC. (C) *p = 0.007, **p = 93
ar ICAM-1 was photoactivated and its dynamics was analyzed by time-lapse
nce intensity in photoactivated canalicular areas (BC) and adjacent basolateral
FP. Quantification of fluorescence in basolateral and canalicular (BC) regions
hown.
r depolarized by PMA treatment for 4 hr, fixed, and stained for ICAM-1.
d for 30 min and crosslinked with secondary antibodies for 30 min at 37C (X-
eManders coefficient, whichmeasures the overlap between the distribution of
pixels that are also positive for clustered ICAM-1 is shown. *p = 0.028; **p =
down for endogenous ICAM-1 for 72 hr and subjected to ICAM-1 crosslinking
FP staining that was positive for p-ERM staining. *p = 0.013; n = 3.
blue staining of the indicated recombinant GST proteins. Bottom, pull-downs
ent were subjected to western blotting for the indicated ERM proteins.
ogenous ICAM-1 and subjected to ICAM-1 crosslinking (X-ICAM-1), fixed, and
>L-GFP. *p = 0.0083; n = 7. Bars show the mean + SEM. Scale bars represent
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Figure 6. TNF-a Increases ICAM-1 Basolateral Localization through Basolateral Activation of ERM Proteins
(A–E) HepG2 cells or HepG2 stably expressing ICAM-1-GFP were grown for 72 hr and then stimulated with 50 ng/ml TNF-a for the indicated times.
(A) HepG2 cells were fixed and stained for endogenous ICAM-1 and F-actin. The enlarged area shows basolateral ICAM-1- and F-actin-rich clusters in
TNF-a-stimulated cells.
(B) TNF-a-stimulated cells were labeled with sulfo-NHS-biotin, followed by neutravidin pull-down assays (Exposed), as in Figure 2. Left, western blot for the
indicated proteins in HepG2 cells expressing ICAM-1-GFP. Asterisks indicate the bands corresponding to ICAM-1-GFP (*) and endogenous ICAM-1 (**). Right
graph: exposed-to-total ratios were calculated for endogenous ICAM-1 in HepG2 cells and for ICAM-1-GFP in HepG2-ICAM-1-GFP cells, and expressed as the
percentage relative to unstimulated cells. *p = 0.044, n = 3; **p = 0.036, n = 4; ***p = 0.028; n = 5.
(C) F-actin- and ICAM-1-rich canalicular structures were quantified in unstimulated cells and cells stimulated with TNF-a for 24 hr.
(D) HepG2-ICAM-1-GFP was left unstimulated or stimulated for 24 hr with TNF-a. Cells were basolaterally labeled with anti-ICAM-1 antibody and incubated at
37C for the indicated times. The percentage of BCs that were positive for basolateral ICAM-1 was quantified. *p = 0.011; **p = 6.925 3 105; n = 3.
(legend continued on next page)
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Figure 7. ICAM-1 Distribution in Human
Livers with Chronic HCV and HBV Infection
(A–C) Immunohistochemical staining of consecu-
tive paraffin sections shows the distribution of
ICAM-1 in the liver parenchyma of a patient with
chronic HCV infection.
(A and B) Four overlapping fields from two
consecutive paraffin sections stained for ICAM-1
and CD10. The enlarged boxed areas show the
canalicular distribution of ICAM-1 and CD10 (ar-
rows, bottom). S, sinusoid.
(B) Apical distribution of ICAM-1 and CD10 in bile
ducts (arrows).
(C) ICAM-1 distribution in another region of the
same liver parenchyma, in which hepatic cells
have lost their apicobasal architecture as revealed
by weaker CD10 staining (left and center)
compared with control samples (Ct) from healthy
donors (right). Note the unpolarized distribution of
ICAM-1. A similar heterogeneous distribution of
hepatic ICAM-1 was observed in tissue sections
from livers chronically infected with HBV.
(D) Immunohistochemical staining of consecutive
liver sections stained for ICAM-1 and CD10, from a
patient with chronic HBV infection. White arrows
point to hepatocytes with unpolarized ICAM-1 and
polarized CD10 distribution. Black arrows point to
hepatocytes with canalicular ICAM-1 staining. Un-
polarized distribution of ICAM-1 in areas in which
polarizedCD10was also observed inHCV-infected
liver parenchyma. Scale bars represent 10 mm.
See also Figure S5.Adhesion Assays
HepG2 cells were plated onto 24-well plates (2.5 3 105/well) for 48 hr. T cells
were labeled with 0.5 mM calcein for 30 min, blocked, and extensively rinsed
with medium. HepG2 cells subjected to different treatments were thoroughly
rinsed and then 3 3 105 T cells per well were added for 15 min. After
washing, fluorescence from calcein-labeled, adhered T cells was detected
with a fluorescent microplate reader (FLUOstar OPTIMA; BMG Labtech).(E) p-ERM staining in HepG2 cells upon TNF-a stimulation. The enlarged area shows microvilli-like structure
(F) Western blot of ICAM-1 and p-ERM (top) and quantification of the p-ERM increase with respect to unstim
0.001; n = 7.
(G) Transfection of a constitutive active mutant form of ERMs (ezrin-TD-GFP) is sufficient to increase basolate
The graph shows the ICAM-1 basolateral index normalized with respect to the F-actin index. *p = 0.026; **p
SEM.
(H) The percentage of BCs that were positive for basolateral ICAM-1 90 min after immunolabeling is reduced
Scale bars represent 10 mm.
See also Figure S4 and Movie S7.
Cell Reports 8, 1879–1893, SepAlternatively, adhesion experiments were also
assayed using a confocal microscope to count
calcein- or CMTMR-labeled T cells that adhered
to HepG2 cell colonies. T cell adhesion was
blocked by incubation of HepG2 cells with
10 mg/ml of mouse anti-ICAM-1 antibody or
T cells with 15 mg/ml of mouse anti-CD11/CD18
(LFA-1) antibody 30 min before adhesion assays
were conducted.
Labeling of Exposed Surface Receptors
HepG2 cells were subjected to various treat-
ments to modulate polarity, rinsed with PBSCa2+/Mg++, and incubated for 20 min with 250 mg/ml of sulfo-NHS-biotin.
The cells were washed and traces of unbound biotin were blocked by in-
cubation for 20 min with Dulbecco’s modified Eagle’s medium plus 10%
fetal calf serum. Labeled HepG2 cells were then lysed with 1% TX-100
in TNE containing protease and phosphatase inhibitors, and neutravidin-
agarose pull-down was performed. All of these procedures were per-
formed at 4C.s in basolateral membrane regions.
ulated cells (bottom). *p = 0.042; **p = 0.019; ***p =
ral localization of ICAM-1 in polarized HepG2 cells.
= 0.005; ***p = 0.001; n = 3. Bars show the mean +
upon ezrin-TD-GFP expression. *p = 0.0003; n = 4.
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Photoactivation and Time-Lapse Confocal Microscopy
HepG2 cells stably expressing photoactivatable ICAM-1-paGFP or ICAM-1-
Dct-paGFP were seeded on a 35-mm glass-bottom culture dish and cultured
for 2 days. Imaging was performed with a 633water immersion objective lens
(Plan-Apochromat; NA 1.0) on an inverted microscope (AxioObserver) equip-
ped with a confocal scanning system (LSM710; Zeiss). Cells were imaged in
phenol-red-free HEPES 20 mM Hank’s balanced salt solution medium in a
heated chamber at 37C. A 405 nm laser was used to photoconvert ICAM-
1-paGFPwithin the defined area of interest. For short videos (up to 10min total
duration) photoactivation was performed using a single pulse at 40% laser po-
wer, followed by time series imaging at 3 s per frame. For videos up to 120min,
the basolateral or apical domain was photoactivated using several pulses at
40% laser power or one single-pulse at 20% laser power, respectively, fol-
lowed by two to three frames at maximum scan speed, and then 1–2 hr at
10 min per frame. Two images were acquired before photoconversion and
their average intensity was taken as background and subtracted from the fluo-
rescence intensity obtained after photoactivation, and then normalized to the
intensity obtained in the first image recorded after photoconversion. Images
were analyzed using ZEN 2010 (Carl Zeiss) and ImageJ (NIH) software.
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